US Broker Ratings

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

PACS Group, Inc. (PACS) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal a 14% Upside Potential

PACS Group, Inc. (NASDAQ: PACS), a leader in the healthcare sector, focuses on operating skilled nursing and assisted living facilities across the United States. Despite market..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 22.48% Potential Upside for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH) is capturing the attention of investors with a compelling potential upside of 22.48%, according to the latest analyst ratings. As..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 16.43% Upside Potential for Investors

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector with a focus on medical devices, offers investors an intriguing opportunity. With a market cap..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Player with a 12.23% Upside Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotech firm focused on autoimmune diseases, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 19.31% Potential Upside in Healthcare

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands as a prominent player in the medical care facilities sector, offering a diversified range of home healthcare services across..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Unlocking a 35% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative focus on cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios is renowned..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unveiling a Potential 362% Upside in Cutting-Edge Immunotherapy

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is captivating investor attention with its innovative approach to cancer treatment. With a market..

Innoviva, Inc. (INVA) Stock Report: Uncovering a 67% Upside Potential in the Biotechnology Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently capturing investor attention with its promising growth trajectory and significant potential upside. Based..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 177.99% Upside

Opko Health, Inc. (NASDAQ: OPK), a key player in the healthcare sector, is stirring interest among investors with its compelling growth potential. Despite its recent challenges,..

GoodRx Holdings Inc. (GDRX) Stock Analysis: Assessing a Potential 76.84% Upside in Health Information Services

GoodRx Holdings, Inc. (NASDAQ: GDRX) represents a unique player in the healthcare sector, particularly within the Health Information Services industry. As a company providing consumers with..

MannKind Corporation (MNKD) Stock Analysis: Unpacking an 84.47% Potential Upside Amid Biotech Innovation

MannKind Corporation (NASDAQ: MNKD) has carved a niche in the healthcare sector, with a focus on developing and commercializing therapeutic products for endocrine and orphan lung..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 40.75% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. Based..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring an 8.87% Potential Upside in the Healthcare Sector

Omnicell, Inc. (NASDAQ: OMCL) is a noteworthy player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.32 billion,..

Harrow, Inc. (HROW) Stock Analysis: A Strong Buy with 47.44% Potential Upside

Investors interested in Harrow, Inc. (NASDAQ: HROW) will find plenty to be optimistic about as the company positions itself as a formidable player in the healthcare..

Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring a 54% Potential Upside

Pulse Biosciences, Inc (NASDAQ: PLSE) is capturing the attention of investors with its innovative approach to bioelectric medicine. Operating within the healthcare sector and specializing in..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Biotech with 55.39% Potential Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector, driven by its innovative approach to tackling diseases associated with dysregulated aldosterone. With a..

Artivion, Inc. (AORT) Stock Analysis: Unlocking a Potential 19% Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, is catching the attention of investors with a compelling..

UFP Technologies (UFPT) Stock Analysis: Exploring a 26% Potential Upside in the Booming Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with a promising potential..

Phreesia, Inc. (PHR) Stock Analysis: Strong Buy Ratings and a 77.90% Potential Upside

Phreesia, Inc. (PHR), a prominent player in the healthcare sector, offers investors a compelling proposition with its integrated SaaS-based software and payment platform tailored for the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds